New cancer clinical trial: A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer

Published on: March 29, 2018 at 12:00PM
Conditions:   Pancreatic Ductal Adenocarcinoma;   Pancreatic Cancer
Interventions:   Drug: PEGylated Recombinant Human Hyaluronidase (PEGPH20);   Drug: Avelumab
Sponsor:   PH Research, S.L.
Recruiting
https://ift.tt/2JbfEnR